1. 1 “Optimizing Your Involvement In Clinical Trials” 2. 2 Investigator Landscape Pre 1995  focus on science  close and collegial  largely academic based …

Slide 1 Slide 2 Depression in Hepatitis C Patients and Interferon Treatment Paul J. Thuluvath, MD, FRCP The Johns Hopkins University School of Medicine Slide 3 1.Evidence…

Slide 1 SYSTEMIC THERAPY FOR UNRESECTABLE STAGE III OR METASTATIC CUTANEOUS MELANOMA Sarkheil Mehdi Hematologist- oncologist Slide 2 Epidemiology Metastatic melanoma accounts…

Slide 1 Russ Miller Director, Center for Computational Research UB Distinguished Professor, Computer Science & Engineering Senior Research Scientist, Hauptman-Woodward…

Interferonlambda and therapy for chronic hepatitis C virus infection Hepatitis is a medical condition defined by 1.the inflammation of the liver and 2.the presence of inflammatory…

Interferonlambda and therapy for chronic hepatitis C virus infection Hepatitis is a medical condition defined by 1.the inflammation of the liver and 2.the presence of inflammatory…

Antiphospholipid antibody syndrome due to interferon treatment for hepatitis C Michi Shinohara, MD Pacific Dermatologic Association August 10, 2008 Case presentation 53…

Slide 1 Maureen J. Donlin Saint Louis University School of Medicine HCV Genetic and Phenotypic Variation in the Context of Antiviral Therapy and Pathology 1 Today I will…

class II-restricted T cells (TH) recognize exogenous antigen. Manipulation of the location of a protein can determine whether it elicits an MHC class I- or class II-restricted…